Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-ε4/4 genotype

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 323-327

  Liu, Rong Yu ^a,b   Zhou, Jiang Ning ^a,b   Van Heerikhuize, Joop ^a,b   Hofman, Michel A ^a,b   Swaab, Dick F ^a,b  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; MELATONIN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN WEIGHT; CEREBROSPINAL FLUID ANALYSIS; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; ONSET AGE; PINEAL BODY; PRIORITY JOURNAL; RESTLESSNESS; RISK FACTOR; SLEEP DISORDER; SUPRACHIASMATIC NUCLEUS;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CIRCADIAN RHYTHM; FEMALE; GENOTYPE; HUMANS; MALE; MELATONIN;

EID: 0032901972     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.323     Document Type: Article

References (52)

1. 1. Reppert SM, Perlow MJ, Ungerleider LG, et al. 1981 Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey. J Neurosci. 1:1414-1425.
2. 2. Swaab DF, Fliers E, Partiman TS. 1985 The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342:37-44.
3. 3. Zhou JN, Hofman MA, Swaab DF. 1995 VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging. 16:571-576.
4. 4. Skene DJ, Vivien-Roels B, Sparks DL, et al. 1990 Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res. 528:170-174.
5. 5. Lebert F, Pasquier F, Petit H. 1996 Sundowning syndrome in demented patients without neuroleptic therapy. Arch Gerontol Geriatr. 22:49-54.
6. 6. Pollak CP, Perlick D. 1991 Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol. 4:204-210.
7. 7. Van Someren EJ, Mirmiran M, Swaab DF. 1993 Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav Brain Res. 57:235-253.
8. 8. Magri F, Terenzi F, Migliorati G, et al. 1997 Biochemical and cerebral morphometric correlates of physiological aging and senile dementia. Aging (Milan). 9:53-54.
9. 9. Pappolla M, Bozner P, Soto C, et al. 1998 Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem. 273:7185-7188.
10. 10. Touitou Y, Fevre M, Lagoguey M, et al. 1981 Age-and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J Endocrinol. 91:467-475.
11. 11. Iguchi H, Kalo KI, Ibayashi H. 1982 Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab. 54:1025-1027.
12. 12. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM. 1986 Human melatonin production decreases with age. J Pineal Res. 3:379-388.
13. 13. Sharma M, Palacios-Bois J, Schwartz G, et al. 1989 Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry. 25:305-319.
14. 14. Ferrari E, Magri F, Dori D, et al. 1995 Neuroendocrine correlates of the aging brain in humans. Neuroendocrinology. 61:464-470.
15. 15. Uchida K, Okamoto N, Ohara K, Morita Y. 1996 Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res. 717:154-159.
16. 16. Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A. 1985 The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm. 61:253-264.
17. 17. Ravid R, Van Zwieten EJ, Swaab DF. 1992 Brain banking and the human hypothalamus-factors to match for, pitfalls and potentials. In: Swaab DF, Hofman MA, Mirmiran M, Ravid R, Van Leeuwen FW, eds. The human hypothalamus in health and disease. Progress in brain research. Amsterdam: Elsevier; 83-95.
18. 18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:939-944.
19. 19. Reisberg B, Ferris SH, de Leon MJ, Crook T. 1982 The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 139:1136-1139.
20. 20. Van de Nes JA, Kamphorst W, Ravid R, Swaab DF. 1993 The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain. 116:103-115.
21. 21. Lerchl A, Partsch CJ. 1994 Reliable analysis of individual human melatonin profiles by complex cosinor analysis. J Pineal Res. 16:85-90.
22. 22. Skene DJ, Churchill A, Raynaud F, Pevet P, Arendt J. 1989 Radioimmunoassay of 5-methoxytryptophol in plasma. Clin Chem. 35:1749-1752.
23. 23. Arendt J. 1985 Mammalian pineal rhythms. Pineal Res Rev. 3:161-213.
24. 24. Arendt J. 1992 The pineal. In: Touitou Y, Haus E, eds. Biological Rhythms In: Clinical and laboratory medicine. Berlin: Springer; 348-362.
25. 25. Maywood ES, Hastings MH, Max M, Ampleford E, Menaker M, Loudon AS. 1993 Circadian and daily rhythms of melatonin in the blood and pineal gland of free-running and entrained Syrian hamsters. J Endocrinol. 136:65-73.
26. 26. Wenham PR, Price WH, Blandell G. 1991 Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1158-1159.
27. 27. Murialdo G, Costelli P, Fonzi S, et al. 1993 Circadian secretion of melatonin and thyrotropin in hospitalized aged patients. Aging (Milan). 5:39-46.
28. 28. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K. 1994 Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand. 89:1-7.
29. 29. Swaab DF, Roozendaal B, Ravid R, Velis DN, Gooren L, Williams RS. 1987 Suprachiasmatic nucleus in aging, Alzheimer's disease, transsexuality and Prader-Willi syndrome. In: Kloet ER, Wiegant VM, de Wied D, eds. Progress in brain research. Amsterdam: Elsevier; 301-310.
30. 30. Hofman MA, Swaab DF. 1994 Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651:134-142.
31. 31. Campbell SS, Kripke DF, Gillin JC, Hrubovcak JC. 1988 Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol Behav. 42:141-144.
32. 32. Van Someren EJ, Kessler A, Mirmiran M, Swaab DF. 1997 Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry. 41:955-963.
33. 33. Touitou Y. 1997 Melatonin and aging: facts and artifacts. Aging Clin Exp Res. 9(Suppl. to No. 4):11.
34. 34. Brzezinski A. 1997 Melatonin in humans. N Engl J Med. 336:186-195.
35. 35. Iguichi H, Kato KI, Ibayashi H. 1982 Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Metab. 55:27-29.
36. 36. Waldhauser F, Weiszenbacher G, Tatzer E, et al. 1988 Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab. 66:648-652.
37. 37. Young IM, Francis PL, Leone AM, Stovell P, Silman RE. 1988 Constant pineal output and increasing body mass account for declining melatonin levels during human growth and sexual maturation. J Pineal Res. 5:71-85.
38. 38. Reiter RJ. 1995 The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol. 30:199-212.
39. 39. Grad BR, Rozencwaig R. 1993 1993 The role of melatonin and serotonin in aging: update [published erratum appears in Psychoneuroendocrinology 18(7):541]. Psychoneuroendocrinology. 18:283-295.
40. 40. Reiter RJ. 1976 Pineal and associated neuroendocrine rhythms. Psychoneuroendocrinology. 1:255-263.
41. 41. Hornykiewicz O. 1983 Dopamine changes in the aging human brain: functional considerations. In: Agnoli A, Crepaldi G, Spano PF, Trabucchi M, eds. Aging brain and ergot alkaloids. New York: Raven Press; 9-14.
42. 42. May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI. 1990 Cerebrospinal fluid production is reduced in healthy aging. Neurology. 40:500-503.
43. 43. Galasko D, Clark C, Chang L, et al. 1997 Assessment of CSF levels of T protein in mildly demented patients with Alzheimer's disease. Neurology. 48:632-635.
44. 44. Rubenstein E. 1998 Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged. Lancet. 351:283-285.
45. 45. Baskett JJ, Cockrem JF, Todd MA. 1991 Melatonin levels in hospitalized elderly patients: a comparison with community based volunteers. Age Ageing. 20:430-434.
46. 46. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. 1980 Light suppresses melatonin secretion in humans. Science. 210:1267-1269.
47. 47. Bruce J, Tamarkin L, Riedel C, Markey S, Oldfield E. 1991 Sequential cerebrospinal fluid and plasma sampling in humans: 24-hour melatonin measurements in normal subjects and after peripheral sympathectomy. J Clin Endocrinol Metab. 72:819-823.
48. 48. Smith JA, Mee TJX, Barnes ND, Torburn RJ, Barnes JLC. 1976 Melatonin in serum and spinal fluid. Lancet. 2:425.
49. 49. Brugger P, Marktl W, Herold M. 1995 Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet. 345:1408.
50. 50. Corder EH, Saunders AM, Strittmatter WJ, et al. 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:921-923.
51. 51. Stengard JH, Pekkanen J, Sulkava R, Ehnholm C, Erkinjuntti T, Nissinen A. 1995 Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand. 92:297-298.
52. 52. Isoe K, Urakami K, Sato K, Takahashi K. 1996 Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand. 93:133-137.